Long-Term Aspirin Use Associated With Reduced Risk Of Dying From Cancer, Study Shows

Active Senior Living
Evidence suggests that aspirin not only reduces the risk of developing cancer, but may also play a strong role in reducing death from cancer, according to lead author of study.

Evidence suggests that aspirin not only reduces the risk of developing cancer, but may also play a strong role in reducing death from cancer, according to lead author of study.

The Washington Post: Long-Term Aspirin Use Associated With Reduced Risk Of Dying From Cancer, Study Shows
Long-term use of aspirin is associated with lower risk of dying from various types of cancers, including colorectal, lung, breast and prostate cancer, according to a study presented at the 2017 American Association for Cancer Research Annual Meeting on Monday. The longitudinal study analyzed the association of aspirin, with varied doses and duration of use, on overall mortality risks and mortality risks from cancer over a nearly 32-year period. (Naqvi, 4/5)

Save